Commercial Credit Report for Master Pharm SA

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Master Pharm SA is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Master Pharm SA
ul. Wersalska 8
Phone: +48 427126200p:+48 427126200	LODZ, 91-203 Poland	Fax: +48 422505447f:+48 422505447

This company is no longer actively traded on any major stock exchange.

Business Summary

Master Pharm SA is a Poland-based company primarily engaged in the manufacture of wellbeing products. The Company specializes in designing and producing diet supplements, food for special nutritional purposes, dietary products, cosmetics, medical devices, as well as other consumables for third parties. Its activities are divided into four operating areas: Contract manufacturing, including designing technology and ingredients of products, manufacturing, packaging, labeling, and marking, among others; Preparation of product documentation, providing product specification, certificate of ingredients and technical etiquette; Import-export, trading with raw materials and food supplements, and Medical Devices, offering medical device design, tests, documentation, and registration. The Company cooperates with Adamed, Bioton, Synoptis, Polpharma, Pharmena, and Salvum, among others. The main shareholder of the Company is Max Welt Holdings Ltd.

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
-	Yes	-	Yes	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
3/31/2022	12/31/2021	Yes	-	-	-	-

Industries

SIC Code	Description
2099	Food preparations, not elsewhere classified
2833	Medicinal chemicals and botanical products
5122	Drugs, drug proprietaries, and druggists' sundries
5169	Chemicals and allied products, not elsewhere classified
6719	Offices of holding companies, not elsewhere classified

Officers and Directors

Title	Name	Age	Title Date	Start Date
Independent Chairman of the Supervisory Board	Marcin B.Konarski	40	7/14/2015	7/14/2015
Chairman of the Management Board	JacekFranasik		10/25/2002	10/25/2002
Independent Member of the Supervisory Board	Stanislaw F.Klimczak	73	6/25/2018	7/14/2015
Member of the Supervisory Board	Jan M.Franasik	74	9/28/2015	9/28/2015
Member of the Supervisory Board	RafalJaskol		6/24/2020	6/24/2020

General Information

Outstanding Shares:	19,788,614	(As of 3/31/2022)
Stock Exchange:	WAR
Fax Number:	+48 422505447